IGF1 and cancer: As the phosphoinositide 3-kinase (PI3K) pathway may trigger the transduction responses mediated by the IGF-1/IGF-1R system in cancer cells [51], we asked whether the PI3K/AKT signaling is involved in the activation of FAK in TNBC cells.